Daclatasvir
Get a Quick Quote Now
Select Packaging
Product Description
Product
Daclatasvir
CAS
1009119-64-5
Formula
C40H50N8O6
Synonym
BMS 790052, BMS-790052, BMS790052, Daclatasvir, UNII-LI2427F9CI, Carbamic acid, N,N'-((1,1'-biphenyl)-4,4'-diylbis(1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl((1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl)))bis C,C'-dimethylester
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Notes
Daclatasvir is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
Daclatasvir
Product Description
Product
Daclatasvir
CAS
1009119-64-5
Formula
C40H50N8O6
Synonym
BMS 790052, BMS-790052, BMS790052, Daclatasvir, UNII-LI2427F9CI, Carbamic acid, N,N'-((1,1'-biphenyl)-4,4'-diylbis(1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl((1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl)))bis C,C'-dimethylester
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Notes
Daclatasvir is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
